Isatuximab plus carfilzomib and dexamethasone versus carfilzomib and dexamethasone in elderly patients with relapsed multiple myeloma: IKEMA subgroup analysis
暂无分享,去创建一个
A. Oriol | P. Moreau | T. Facon | L. Rosiñol | K. Yong | M. Cavo | T. Martin | I. Špička | G. Mikala | M. Yağcı | M. Risse | G. Asset | Youngil Koh | G. Martinez | A. Lim | Sandrine Schwab | Y. Koh | Andrew B M Lim | I. Spicka